Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Systemic and local diffusion of ethanol after percutaneous administration in congenital venous malformations
2009-011276-29Phase 2Completed
- Sponsor
- Orphagen Therapeutics
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of ethanol in venous malformation (VM) (2 arms), sponsored by Orphagen Therapeutics. Primary endpoint: Cmax. Started May 2009; status: completed.
02
Drugs
ethanol
03
Conditions
venous malformation (VM)
Beyond the preview
Go deeper on 2009-011276-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011276-29.